Ameriprise’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.02M Buy
281,059
+220,764
+366% +$4.75M ﹤0.01% 2210
2026
Q1
$692K Sell
60,295
-281,987
-82% -$3.97M ﹤0.01% 3452
2025
Q4
$4.92M Buy
342,282
+280,634
+455% +$4.85M ﹤0.01% 2446
2025
Q3
$1.14M Sell
61,648
-808,031
-93% -$13.3M ﹤0.01% 3300
2025
Q2
$18.6M Sell
869,679
-433,848
-33% -$6.45M ﹤0.01% 1406
2025
Q1
$17.1M Buy
1,303,527
+326,964
+33% +$4.85M ﹤0.01% 1412
2024
Q4
$13.1M Buy
976,563
+945,682
+3,062% +$15.2M ﹤0.01% 1608
2024
Q3
$655K Sell
30,881
-59,088
-66% -$1.06M ﹤0.01% 3384
2024
Q2
$1.42M Sell
89,969
-310,208
-78% -$5.7M ﹤0.01% 3009
2024
Q1
$5.95M Buy
+400,177
New +$5.48M ﹤0.01% 2231
2023
Q4
Sell
-47,414
Closed -$264K 3959
2023
Q3
$264K Buy
+47,414
New +$332K ﹤0.01% 3615
2023
Q2
Sell
-17,396
Closed -$114K 3977
2023
Q1
$114K Sell
17,396
-64,388
-79% -$263K ﹤0.01% 3809
2022
Q4
$201K Sell
81,784
-336
-0.4% -$1.05K ﹤0.01% 3704
2022
Q3
$410K Buy
+82,120
New +$479K ﹤0.01% 3462

Other funds holding OSCR

Ameriprise's OSCR Position: Q2 2026 in Review

Ameriprise increased its Oscar Health (OSCR) stake by 366% in Q2 2026, buying an estimated $4.75M and bringing the position to 281,059 shares worth $8.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2210.

Ameriprise first reported a position in OSCR in Q3 2022 and has held it in 14 quarters since. The position peaked at $18.6M in Q2 2025. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Ameriprise held 281,059 shares of Oscar Health worth $8.02M as of Q2 2026.
  • Ameriprise bought 220,764 Oscar Health shares in Q2 2026, an estimated $4.75M.
  • Oscar Health made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2210 holding.
  • Ameriprise first reported a position in Oscar Health in Q3 2022 and has held it in 14 quarters since.
  • Ameriprise's Oscar Health position peaked at $18.6M in Q2 2025.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.